TABLE 1.
MICs for the S. epidermidis isolates investigated
| Isolate | Type of infection | Antibiotic treatment | MIC (mg/liter) of the following druga:
|
|||||
|---|---|---|---|---|---|---|---|---|
| AZI | VAN | DAP | FOS | TIG | CRX | |||
| SE19 | Pacemaker infection | None | 0.06 | 2 | 0.25 | 32 | 0.125 | 16 |
| SE25 | Implanted defibrillator infection | None | 0.125 | 2 | 0.25 | 4 | 0.125 | 64 |
| SE32 | Hip prosthesis | Ceftriaxone | >256 | 1 | 0.25 | 32 | 0.06 | 16 |
| SE99 | Knee prosthesis | None | >256 | 2 | 0.125 | >256 | 0.25 | 32 |
| SE42 | Hip prosthesis | None | 0.06 | 1 | 0.25 | 16 | 0.06 | 1 |
| SE1 | Intravascular catheter-related bacteremia | Cefuroxime | >256 | 2 | 0.125 | 1 | 0.06 | 16 |
| SE4 | Intravascular catheter-related bacteremia | Amoxicillin-clavulanic acid | >256 | 1 | 0.5 | 32 | 0.5 | 16 |
| SE14 | Intravascular catheter-related bacteremia | Ceftriaxone | 0.125 | 2 | 0.25 | 128 | 0.06 | 1 |
| SEK1 | Skin isolate | None | >256 | 0.5 | 0.025 | 16 | 0.06 | 1 |
| SEK15 | Skin isolate | None | 0.125 | 1 | 0.25 | 2 | 0.06 | 1 |
| ATCC 29213 | 0.25 | 1 | 0.125 | 2 | 0.25 | 4 | ||
| DSM3269 | 0.25 | 2 | 0.25 | 1 | 0.5 | 0.5 | ||
a
AZI, azithromycin; VAN, vancomycin; DAP, daptomycin; FOS, fosfomycin; TIG, tigecycline; CRX, ceftriaxone.